Newsfeeds Archive - Page 2 of 4

4 minute read

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

January 18, 2:25 PM

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.

ACGN

3 minute read

Nasdaq Edges Higher; Neovasc Shares Jump

By Lisa Levin

January 17, 3:50 PM

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

ANGN

4 minute read

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

January 17, 2:21 PM

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.

ACER

3 minute read

Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views

By Lisa Levin

January 17, 1:07 PM

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

ANGN

1 minute read

Calyxt And Cibus Announce All-Stock Merger Agreement; Calyxt To Issue Shares In Exchange Ratio Such That Calyxt Shareholders Will Own ~5% Of Combined Co.

By Benzinga Newsdesk

January 17, 7:32 AM

Under the terms of the merger agreement, Calyxt will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will own

CLXT

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

November 25, 9:07 AM

Gainers LifeStance Health Gr (NASDAQ:LFST) stock increased by 37.0% to $6.89 during Friday’s pre-market session. The market value…

APGN

1 minute read

Calyxt Achieves Phase 1 Milestone In Collaboration Agreement To Develop Alternative To Palm Oil

By Benzinga Newsdesk

November 18, 12:01 PM

Calyxt, Inc. (NASDAQ:CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its research collaboration agreement with a leading global food ingredient

CLXT

2 minute read

News

Calyxt Granted 180-Day Extension By Nasdaq To Regain Compliance With Bid Price Rule

By Benzinga Newsdesk

November 17, 5:03 PM

Calyxt, Inc (NASDAQ:CLXT) a plant-based synthetic biology focused on engineering sustainable ingredients for customers in the cosmeceutical, nutraceutical and pharmaceutical industries, today announced that the Company

CLXT